Is Moderna listed on the ASX?

Can ASX investors buy Moderna shares?

Key points
  • Moderna has become a household name in recent years for obvious reasons
  • The company has made news today by announcing a new vaccine manufacturing hub in Victoria
  • But are Moderna shares available for ASX investors?

Is Moderna listed on the ASX? The vaccine company has become a household name over the past two years. Moderna vaccines were approved for use against COVID-19 back in August last year. Since then, countless doses have been put in arms across the country.

What's more, we got the news today that the Federal Government and the Victorian Government has partnered up with Moderna to build the first mRNA vaccine manufacturing hub in the Southern Hemisphere.

According to reporting from the ABC, the two governments will provide support for Moderna to construct a manufacturing facility in Victoria. The exact location is yet to be determined. According to the report, all parties are hoping that the new plant will produce its first vaccines "sometime in 2024". But the facility will not be restricted to just COVID vaccines. There are "plans to develop a number of other respiratory treatments and vaccines" too. These are likely to include influenza (the flu) and respiratory syncytial virus.

So now Moderna is set to have such a strong presence in Australia, many investors might be hoping to get a piece of the action in their own portfolios. So is Moderna an ASX listed share?

A doctor looks unsure.

Image source: Getty images

Are Moderna shares on the ASX?

Unfortunately, the answer is no.

Moderna is indeed a public company. But it is an American one through and through, having been founded in Massachusetts in 2010. As such, Moderna shares are listed on the US markets. Specifically, the company is on the Nasdaq exchange. Its full name is Moderna Inc (NASDAQ: MRNA). That's a highly applicable ticker code if there ever was one.

So unfortunately for ASX investors, we can't buy Moderna shares directly on the ASX. If you wanted to buy the company's shares, you would need to do so by buying the US-listed shares through a supporting broker.

Alternatively, Moderna is a constituent of both the S&P 500 Index (INDEXSP: .INX) and the NASDAQ-100 Index (NASDAQ: NDX). Both of these indexes have ASX exchange-traded funds (ETFs) that track them. So that is another avenue to explore for any aspiring Moderna investors.

But, as is the case with many global companies, there just isn't a direct ASX listing for us Aussies to go with.

The Moderna share price is currently up by 35.8% over the past 12 months, although it has taken a 24% haircut in 2022 so far. At the last Moderna share price of US$178.73, the company had a market capitalisation of US$72.03 billion.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Moderna Inc. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Smiling man working on his laptop.
Best Shares

BHP vs Codan: Which ASX 200 share is the stronger buy today?

BHP and Codan are both flying, but which ASX share is truly the better buy today? I break down the…

Read more »

Watering can pouring water on increasing piles of coins with green plants on them and a piggy bank and coins on the table.
Opinions

$3,000 buys 1,463 shares in an impressively reliable ASX dividend stock

Here’s what makes this stock one of the best picks for dividends, in my view.

Read more »

A woman is very excited about something she's just seen on her computer, clenching her fists and smiling broadly.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week for investors this Friday.

Read more »

REIT on wooden circles with real estate investment trust written above on a yellow background.
REITs

6 ASX REITs just hit 52-week lows. Do any brokers say buy?

Several ASX real estate investment trusts (REITs) have hit 52-week lows as the property sector underperforms the market on Friday.…

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: CBA, Capstone Copper, Codan shares

Let's take a look at some new ratings from the experts.

Read more »

a woman peers over a surface with a happy, curious look on her face with eyes wide as though she is overhearing something.
Broker Notes

5 ASX 200 shares brokers tip to rocket 25% to 77%

Looking for buy-the-dip opportunities in today's weak market? Experts reveal their buy calls.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Morgans tips 290% upside for this up-and-coming ASX copper company

This company is in the right place at the right time, the broker says.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

In a tough retail environment, what's the outlook for Wesfarmers shares?

Analysts argue the major retailer is resilient in the face of tough trading conditions.

Read more »